沙美特罗替卡松吸入粉雾剂 | Laboratoire GlaxoSmithKline | 每泡含昔萘酸沙美特罗50μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松500μg,递送剂量为昔萘酸沙美特罗47μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松460μg | Glaxo Wellcome Production | 国药准字HJ20150325 | 2024-10-29 | 查看 |
沙美特罗替卡松吸入粉雾剂 | Laboratoire GlaxoSmithKline | 每泡含昔萘酸沙美特罗50μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松250μg,递送剂量为昔萘酸沙美特罗47μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松231μg | Glaxo Wellcome Production | 国药准字HJ20150324 | 2024-10-29 | 查看 |
沙美特罗替卡松吸入粉雾剂 | Laboratoire GlaxoSmithKline | 每泡含昔萘酸沙美特罗50μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松100μg,递送剂量为昔萘酸沙美特罗47μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松92μg | Glaxo Wellcome Production | 国药准字HJ20150323 | 2024-10-29 | 查看 |
沙美特罗替卡松吸入气雾剂 | Laboratoire GlaxoSmithKline | 每瓶120揿,每揿含昔萘酸沙美特罗25μg(按C₂₅H₃₇NO₄计)和丙酸氟替卡松250μg,递送剂量为昔萘酸沙美特罗21μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松220μg。 | Glaxo Wellcome Production | 国药准字HJ20140404 | 2024-04-18 | 查看 |